SBIR/STTR Research Award
Gene Expression in Engineered Human Skin
Award amount
$125,735Program and phase
STTR · Phase IAward year
2001Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- Dermigen, Inc.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
DESCRIPTION (provided by applicant): Exposure of humans to sunlight produces
adaptive and pathological responses in the skin, including erythema
(inflammation), tanning, photoaging, photoallergy and carcinogenesis. These
responses involve the modulation of gene expression and excessive exposure can
result in mutation and tumorigenesis. The effects produced by ultraviolet
radiation (UVR) can be modulated by a number of chemicals applied topically or
systemically. The proposed research will explore the use of engineered human
skin (EHS), an in vitro model possessing a dermis and differentiated epidermis,
to evaluate chemical agents that modulate UVR-induced responses in skin.
Initial studies (Phase I) will focus on proof-of-concept using EHS and gene
expression technology to identify a set of genes that undergo modulation in
response to exposure to simulated sunlight. Follow-on research (Phase II) will
validate the model using a defined set of known chemical modulators of
UVR-induced skin damage and will extend these studies to the use of EHS
incorporating adnexal specialized cell types, e.g. melanocytes and Langerhans
cells. Gene expression will be monitored after single and multiple exposures to
UVR. Identification of gene expression biomarkers will allow the development of
reagents or processes to screen for protective or deleterious effects of
chemical agents on UVR-exposed EHS, potentially reducing the need for assays
using experimental animals or human subjects.
PROPOSED COMMERCIAL APPLICATION:
The proposed research utilizes engineered human skin (an in vitro model possessing a dermis and differentiated epidermis) and gene expression technology to identify a set of genes that undergoes modulation in response to exposure to ultraviolet radiation (UVR). Identification of such biomarkers will allow the development of reagents or processes to screen for protective or deleterious effects of chemical agents on UVR exposed human skin, potentially reducing the need for assays using experimental animals or human subjects.
Technology keywords
Not reported